Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2026 Earnings Call Transcript
Operator: Good day, and welcome to the Q1 2026 Harvard Biosciences, Inc. Earnings Conference Call. [Operator Instructions] Please note, this call is being recorded.
Harvard Bioscience Inc (HBIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Meros Investment Management Timothy Chatard | 182,992 | $1,125,401 | +55% | 0.36% |
| 2. | Corsair Capital Management Jay Petschek And Steven Major | 122,810 | $755,282 | -2% | 0.09% |
| 3. | Renaissance Technologies Jim Simons | 99,327 | $610,861 | -3% | 0% |
| 4. | Millennium Management Israel Englander | 32,620 | $200,613 | -30% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 13,251 | $81,494 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 5,000 | $25,000.00 | 17,500 | 2026-03-16 | Filing | |
| $4.87 | 10,000 | $48,700.00 | 21,000 | 2026-03-17 | Filing | |
| $4.85 | 8,475 | $41,103.75 | 32,000 | 2026-03-17 | Filing | |
| $4.99 | 12,525 | $62,499.75 | 23,525 | 2026-03-16 | Filing | |
| $5.01 | 5,000 | $25,050.00 | 105,000 | 2026-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.02 | 48,175 | $386,363.50 | 2,091,725 | 2021-08-23 | Filing | |
| $7.14 | 24,312 | $173,587.68 | 2,279,778 | 2021-05-21 | Filing | |
| $7.03 | 14,876 | $104,578.28 | 2,279,778 | 2021-05-20 | Filing | |
| $7.17 | 39,188 | $280,977.96 | 2,279,778 | 2021-05-19 | Filing | |
| $7.41 | 39,188 | $290,383.08 | 2,279,788 | 2021-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 310,861 | $1,911,795 | 1.63% | |
| 2. | 169,625 | $1,043,194 | 0% | |
| 3. | 143,082 | $879,954 | 0.68% | |
| 4. | 61,834 | $380,280 | 0% | |
| 5. | 47,555 | $292,534 | 0% |
News See All
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Fourth Quarter and Full Year 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript
Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Harvard Bioscience, Inc. Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center